United Kingdom
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.20 B
|
March 31, 2024 | USD 10.94 | 1.86% |
|
United Kingdom |
|
2 |
USD 20.90 M
|
Dec. 31, 2023 | USD 5.61 | -4.92% |
|
United Kingdom |
|
3 |
USD 14.68 M
|
Aug. 31, 2023 | USD 0.16 | -0.68% |
|
United Kingdom |
|
4 |
USD 8.30 M
|
Dec. 31, 2023 | USD 0.71 | 0.09% |
|
United Kingdom |
|
5 |
USD 3.67 M
|
Dec. 31, 2023 | USD 1.04 | 1.96% |
|
United Kingdom |
|
6 |
USD 3.58 M
|
Dec. 31, 2023 | USD 0.03 | -2.14% |
|
United Kingdom |
|
7 |
USD 3.57 M
|
Dec. 31, 2023 | USD 4.79 | -4.31% |
|
United Kingdom |
|
8 |
USD 1.41 M
|
Dec. 31, 2023 | USD 0.21 | 0.09% |
|
United Kingdom |
|
9 |
USD 468.31 K
|
June 30, 2024 | USD 0.31 | 0.09% |
|
United Kingdom |
|
10 |
USD 240.17 K
|
Dec. 31, 2023 | USD 0.04 | -14.59% |
|
United Kingdom |
|
11 |
USD 222.35 K
|
April 30, 2024 | USD 0.11 | -4.08% |
|
United Kingdom |
|
12 |
USD 173.04 K
|
Dec. 31, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
|
13 |
USD 1.27 K
|
June 30, 2024 | USD 0.03 | -4.36% |
|
United Kingdom |
|
14 |
USD 1.26 K
|
March 31, 2024 | USD 0.11 | -6.40% |
|
United Kingdom |
|
15 |
USD 0.00
|
March 31, 2024 | USD 1.03 | NA |
|
United Kingdom |
|
16 |
USD 0.00
|
Dec. 31, 2023 | USD 48.44 | 3.75% |
|
United Kingdom |
|
17 |
USD -3.10 K
|
Dec. 31, 2023 | USD 0.02 | 2.68% |
|
United Kingdom |
|
18 |
USD -20.13 K
|
June 30, 2024 | USD 39.06 | 2.49% |
|
United Kingdom |
|
19 |
USD -29.11 K
|
June 30, 2024 | USD 0.27 | 2.36% |
|
United Kingdom |
|
20 |
USD -29.11 K
|
June 30, 2024 | USD 0.10 | 0.09% |
|
United Kingdom |
|
21 |
USD -40.64 K
|
Dec. 31, 2023 | USD 4.80 | 0.73% |
|
United Kingdom |
|
22 |
USD -66.89 K
|
Dec. 31, 2023 | USD 0.04 | -9.47% |
|
United Kingdom |
|
23 |
USD -107.25 K
|
March 31, 2024 | USD 0.15 | 0.09% |
|
United Kingdom |
|
24 |
USD -231.00 K
|
Dec. 31, 2023 | USD 0.05 | -16.59% |
|
United Kingdom |
|
25 |
USD -258.28 K
|
Dec. 31, 2023 | USD 0.14 | 0.09% |
|
United Kingdom |
|
26 |
USD -337.17 K
|
Dec. 31, 2023 | USD 4.18 | -2.79% |
|
United Kingdom |
|
27 |
USD -381.70 K
|
Dec. 31, 2023 | USD 0.05 | 0.09% |
|
United Kingdom |
|
28 |
USD -381.70 K
|
Dec. 30, 2023 | USD 72.03 | -1.91% |
|
United Kingdom |
|
29 |
USD -419.00 K
|
Dec. 31, 2023 | USD 3.06 | -8.38% |
|
United Kingdom |
|
30 |
USD -433.86 K
|
Dec. 31, 2023 | USD 0.20 | 0.09% |
|
United Kingdom |
|
31 |
USD -504.19 K
|
Sept. 30, 2024 | USD 0.14 | 0.09% |
|
United Kingdom |
|
32 |
USD -539.47 K
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
|
33 |
USD -577.41 K
|
Nov. 30, 2023 | USD 0.03 | 0.09% |
|
United Kingdom |
|
34 |
USD -837.00 K
|
Dec. 31, 2023 | USD 0.70 | -2.31% |
|
United Kingdom |
|
35 |
USD -843.16 K
|
Sept. 30, 2023 | USD 0.01 | -33.27% |
|
United Kingdom |
|
36 |
USD -1.16 M
|
March 31, 2024 | USD 2.29 | -3.78% |
|
United Kingdom |
|
37 |
USD -1.52 M
|
June 30, 2024 | USD 0.09 | 2.54% |
|
United Kingdom |
|
38 |
USD -1.67 M
|
May 31, 2024 | USD 0.24 | -4.72% |
|
United Kingdom |
|
39 |
USD -1.90 M
|
Dec. 31, 2023 | USD 15.26 | 0.09% |
|
United Kingdom |
|
40 |
USD -2.91 M
|
June 30, 2024 | USD 0.19 | -3.04% |
|
United Kingdom |
|
41 |
USD -2.93 M
|
Dec. 31, 2023 | USD 14.81 | -2.31% |
|
United Kingdom |
|
42 |
USD -3.59 M
|
Dec. 31, 2023 | USD 0.13 | -2.30% |
|
United Kingdom |
|
43 |
USD -3.79 M
|
Sept. 30, 2024 | USD 0.36 | 3.24% |
|
United Kingdom |
|
44 |
USD -3.84 M
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
45 |
USD -4.31 M
|
March 31, 2024 | USD 0.78 | -0.69% |
|
United Kingdom |
|
46 |
USD -5.41 M
|
Dec. 31, 2023 | USD 0.95 | 0.80% |
|
United Kingdom |
|
47 |
USD -5.42 M
|
Dec. 31, 2023 | USD 28.56 | -4.90% |
|
United Kingdom |
|
48 |
USD -6.23 M
|
April 30, 2024 | USD 0.64 | 0.47% |
|
United Kingdom |
|
49 |
USD -7.18 M
|
Dec. 31, 2023 | USD 0.31 | 0.09% |
|
United Kingdom |
|
50 |
USD -10.99 M
|
Dec. 31, 2023 | USD 2.21 | -3.91% |
|
United Kingdom |
The Biotechnology company in United Kingdom with the highest Net Cash Used For Investing Activities is Roivant Sciences Ltd. (NasdaqGS: ROIV) at USD 5.20 B.
The Biotechnology company in United Kingdom with the lowest Net Cash Used For Investing Activities is AstraZeneca PLC (LSE: AZN.L) at USD -4.06 B.
The top 10 Biotechnology companies in United Kingdom by Net Cash Used For Investing Activities are Roivant Sciences Ltd., Silence Therapeutics plc, Oncimmune Holdings plc, Arecor Therapeutics plc, NuCana plc, Synairgen plc, Oxford Biomedica plc, OptiBiotix Health Plc, Frontier IP Group Plc and ImmuPharma plc.
The bottom 10 Biotechnology companies in United Kingdom by Net Cash Used For Investing Activities are AstraZeneca PLC, Clarivate Plc, Oxford Nanopore Technologies plc, Genus plc, Creo Medical Limited, Science Group plc, Avacta Group Plc, Autolus Therapeutics plc, EKF Diagnostics Holdings plc and SDI Group plc.